Range
3.29 - 3.62
Vol / Avg.
577.6K/594.3K
Div / Yield
-
52 Wk
2.08 - 7.55
Mkt Cap
146.3M
Payout Ratio
-
Open
3.56
P/E
-
EPS
-0.45
Shares
43.3M
Outstanding
43.3M
Total Float
35.9M
load more
Sector: Health Care.Industry: Biotechnology
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-04
REV
Q2 2021Est.ActualSurprise
EPS-0.430
REV3.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CYCNCyclerion Therapeutics-3.15%146.3M

Cyclerion Therapeutics Questions & Anwsers

Q

How do I buy Cyclerion Therapeutics (CYCN) stock?

A

You can purchase shares of Cyclerion Therapeutics (NASDAQ: CYCN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Cyclerion Therapeutics's (CYCN) competitors?

Q

What is the target price for Cyclerion Therapeutics (CYCN) stock?

A

The latest price target for Cyclerion Therapeutics (NASDAQ: CYCN) was reported by Cantor Fitzgerald on September 24, 2021. The analyst firm set a price target for 7.00 expecting CYCN to rise to within 12 months (a possible 107.10% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Cyclerion Therapeutics (CYCN)?

A

The stock price for Cyclerion Therapeutics (NASDAQ: CYCN) is $3.38 last updated Fri Sep 24 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Cyclerion Therapeutics (CYCN) pay a dividend?

A

There are no upcoming dividends for Cyclerion Therapeutics.

Q

When is Cyclerion Therapeutics (NASDAQ:CYCN) reporting earnings?

A
Cyclerion Therapeutics’s Q3 earnings are confirmed for after-market on November 4, 2021.
Q

Is Cyclerion Therapeutics (CYCN) going to split?

A

There is no upcoming split for Cyclerion Therapeutics.

Q

What sector and industry does Cyclerion Therapeutics (CYCN) operate in?

A

Cyclerion Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.